Read More

Connect Biopharma To Host A Conference Call Tuesday, October 4 To Discuss Topline Results For The Pivotal Trial In China Of Lead Candidate, CBP-201, In Patients With Moderate-To-Severe Atopic Dermatitis

Conference call and webcast to take place at 5:30 a.m. PDT/8:30 a.m. EDT, tomorrow, Tuesday, October 4 SAN DIEGO and TAICANG, SUZHOU, China, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited